Eastern Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Buy
2,710
+396
+17% +$52.2K 0.01% 328
2026
Q1
$323K Buy
2,314
+63
+3% +$8.82K 0.01% 319
2025
Q4
$276K Buy
2,251
+1,426
+173% +$173K ﹤0.01% 322
2025
Q3
$91.6K Hold
825
﹤0.01% 463
2025
Q2
$91.5K Sell
825
-250
-23% -$26.6K ﹤0.01% 458
2025
Q1
$120K Hold
1,075
﹤0.01% 421
2024
Q4
$99.3K Hold
1,075
﹤0.01% 470
2024
Q3
$90.1K Buy
+1,075
New +$82K ﹤0.01% 479

Other funds holding GILD

Eastern Bank's GILD Position: Q2 2026 in Review

Eastern Bank increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $52.2K and bringing the position to 2,710 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #328.

Eastern Bank first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Eastern Bank held 2,710 shares of Gilead Sciences worth $342K as of Q2 2026.
  • Eastern Bank bought 396 Gilead Sciences shares in Q2 2026, an estimated $52.2K.
  • Gilead Sciences made up 0.01% of Eastern Bank's portfolio in Q2 2026, its #328 holding.
  • Eastern Bank first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.